{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:20:26Z","timestamp":1788279626026,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,13]],"date-time":"2027-08-13T00:00:00Z","timestamp":1818115200000},"content-version":"am","delay-in-days":255,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI121281"],"award-info":[{"award-number":["R01AI121281"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of War","doi-asserted-by":"publisher","award":["W81XWH-21-1-0527"],"award-info":[{"award-number":["W81XWH-21-1-0527"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of War","doi-asserted-by":"publisher","award":["W81XWH-21-1-0526"],"award-info":[{"award-number":["W81XWH-21-1-0526"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bioadv.2026.215100","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:18:06Z","timestamp":1786342686000},"page":"215100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Condensate enabled delivery of Fas and IL-2 receptor agonists promotes T regulatory responses to alloantigens"],"prefix":"10.1016","volume":"189","author":[{"given":"Kathleen M.","family":"Yee-Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Badal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Tarique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma S.","family":"Yolcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haval","family":"Shirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5215","key":"10.1016\/j.bioadv.2026.215100_bb0005","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bioadv.2026.215100_bb0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/373444a0","article-title":"Fas(CD95)\/FasL interactions required for programmed cell death after T-cell activation","volume":"373","author":"Ju","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bioadv.2026.215100_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/373441a0","article-title":"Cell-autonomous Fas (CD95)\/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas","volume":"373","author":"Brunner","year":"1995","journal-title":"Nature"},{"issue":"6367","key":"10.1016\/j.bioadv.2026.215100_bb0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/356314a0","article-title":"Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis","volume":"356","author":"Watanabe-Fukunaga","year":"1992","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215100_bb0025","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0092-8674(94)90375-1","article-title":"Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand","volume":"76","author":"Takahashi","year":"1994","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioadv.2026.215100_bb0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4049\/jimmunol.169.2.750","article-title":"Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells","volume":"169","author":"Banz","year":"2002","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215100_bb0035","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.182.3.1469","article-title":"Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis","volume":"182","author":"Strauss","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215100_bb0040","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.4049\/jimmunol.157.10.4309","article-title":"Human T cells require IL-2 but not G1\/S transition to acquire susceptibility to Fas-mediated apoptosis","volume":"157","author":"Fournel","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioadv.2026.215100_bb0045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1074-7613(00)80566-X","article-title":"Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis","volume":"8","author":"Refaeli","year":"1998","journal-title":"Immunity"},{"issue":"6347","key":"10.1016\/j.bioadv.2026.215100_bb0050","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/353858a0","article-title":"Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis","volume":"353","author":"Lenardo","year":"1991","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bioadv.2026.215100_bb0055","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.191.7.1209","article-title":"Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival","volume":"191","author":"Hohlbaum","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioadv.2026.215100_bb0060","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","article-title":"Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity","volume":"187","author":"Schneider","year":"1998","journal-title":"J. Exp. Med."},{"issue":"7264","key":"10.1016\/j.bioadv.2026.215100_bb0065","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nature08402","article-title":"Membrane-bound Fas ligand only is essential for Fas-induced apoptosis","volume":"461","author":"O' Reilly","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bioadv.2026.215100_bb0070","first-page":"566","article-title":"A novel approach to transplantation tolerance: FasL-decorated donor splenocytes prevent heart allograft rejection","volume":"5","author":"Yolcu","year":"2005","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215100_bb0075","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1161\/01.CIR.0000064893.96179.7E","article-title":"Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection","volume":"107","author":"Askenasy","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215100_bb0080","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1074-7613(02)00482-X","article-title":"Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection","volume":"17","author":"Yolcu","year":"2002","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.bioadv.2026.215100_bb0085","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ajt.15747","article-title":"Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege","volume":"20","author":"Woodward","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.bioadv.2026.215100_bb0090","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1111\/ajt.12944","article-title":"Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice","volume":"14","author":"Pilon","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215100_bb0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215100_bb0100","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db12-0049","article-title":"Rapamycin\/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs beta-cell function","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"issue":"22","key":"10.1016\/j.bioadv.2026.215100_bb0105","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215100_bb0110","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.20100209","article-title":"IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells","volume":"207","author":"Grinberg-Bleyer","year":"2010","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215100_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2004.07.098","article-title":"Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif","volume":"322","author":"Shiraishi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioadv.2026.215100_bb0120","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/364806a0","article-title":"Lethal effect of the anti-Fas antibody in mice","volume":"364","author":"Ogasawara","year":"1993","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bioadv.2026.215100_bb0125","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.137.5.1735","article-title":"Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2","volume":"137","author":"Rosenstein","year":"1986","journal-title":"J. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.bioadv.2026.215100_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0162-3109(97)00041-6","article-title":"Vascular leak syndrome: a side effect of immunotherapy","volume":"37","author":"Baluna","year":"1997","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bioadv.2026.215100_bb0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2010.11.025","article-title":"A [polycation:heparin] complex releases growth factors with enhanced bioactivity","volume":"150","author":"Chu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.215100_bb0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.biomaterials.2015.08.050","article-title":"Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair","volume":"72","author":"Chen","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2026.215100_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jconrel.2015.03.034","article-title":"Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction","volume":"207","author":"Awada","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.215100_bb0150","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mabi.201300486","article-title":"Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects","volume":"14","author":"Awada","year":"2014","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.bioadv.2026.215100_bb0155","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jconrel.2019.12.035","article-title":"Single injection of IL-12 coacervate as an effective therapy against B16-F10 melanoma in mice","volume":"318","author":"Hwang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2026.215100_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202370020","article-title":"Condensate-filled lipid vesicles for protein delivery","volume":"23","author":"Yeh","year":"2023","journal-title":"Macromol. Biosci."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215100_bb0165","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.exphem.2007.07.010","article-title":"Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis","volume":"35","author":"Pearl-Yafe","year":"2007","journal-title":"Exp. Hematol."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215100_bb0170","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/jbm.a.37429","article-title":"A hydrogel platform for co-delivery of immunomodulatory proteins for pancreatic islet allografts","volume":"110","author":"Medina","year":"2022","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"33","key":"10.1016\/j.bioadv.2026.215100_bb0175","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1073\/pnas.1110121108","article-title":"Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis","volume":"108","author":"Chu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.bioadv.2026.215100_bb0180","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1039\/D6BM00335D","article-title":"Stable, micron-scale lipocondensates achieving prolonged circulation without PEGlyated lipids","volume":"14","author":"Yeh","year":"2026","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215100_bb0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/TP.0b013e31815e883e","article-title":"A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection","volume":"85","author":"Brennan","year":"2008","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.bioadv.2026.215100_bb0190","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1634\/stemcells.2007-0402","article-title":"Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors","volume":"25","author":"Pearl-Yafe","year":"2007","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.bioadv.2026.215100_bb0195","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.molimm.2007.01.014","article-title":"A novel multimeric form of FasL modulates the ability of diabetogenic T cells to mediate type 1 diabetes in an adoptive transfer model","volume":"44","author":"Franke","year":"2007","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.bioadv.2026.215100_bb0200","first-page":"2009","article-title":"Pharmacokinetics of recombinant interleukin 2 in humans","volume":"50","author":"Konrad","year":"1990","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215100_bb0205","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.4049\/jimmunol.130.5.2203","article-title":"The fate of interleukin-2 after in vivo administration","volume":"130","author":"Donohue","year":"1983","journal-title":"J. Immunol."},{"issue":"21","key":"10.1016\/j.bioadv.2026.215100_bb0210","article-title":"Hybrid biomaterial initiates refractory wound healing via inducing transiently heightened inflammatory responses","volume":"9","author":"Liu","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"6","key":"10.1016\/j.bioadv.2026.215100_bb0215","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/ndt\/gfr693","article-title":"Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy","volume":"27","author":"Krystufkova","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215100_bb0220","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.4049\/jimmunol.1003266","article-title":"Pancreatic islets engineered with SA-FasL protein establish robust localized tolerance by inducing regulatory T cells in mice","volume":"187","author":"Yolcu","year":"2011","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215100_bb0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/intimm\/dxt016","article-title":"Killer Treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation","volume":"25","author":"Kaminitz","year":"2013","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215100_bb0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2011.03.003","article-title":"Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice","volume":"37","author":"Kaminitz","year":"2011","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215100_bb0235","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.181.2.931","article-title":"Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand protein","volume":"181","author":"Yolcu","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioadv.2026.215100_bb0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biomaterials.2018.11.015","article-title":"Localized immune tolerance from FasL-functionalized PLG scaffolds","volume":"192","author":"Skoumal","year":"2019","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.bioadv.2026.215100_bb0245","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41563-018-0099-0","article-title":"Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance","volume":"17","author":"Headen","year":"2018","journal-title":"Nat. Mater."},{"issue":"19","key":"10.1016\/j.bioadv.2026.215100_bb0250","doi-asserted-by":"crossref","first-page":"eabm9881","DOI":"10.1126\/sciadv.abm9881","article-title":"FasL microgels induce immune acceptance of islet allografts in nonhuman primates","volume":"8","author":"Lei","year":"2022","journal-title":"Sci. Adv."},{"issue":"11 Suppl 13","key":"10.1016\/j.bioadv.2026.215100_bb0255","first-page":"11","article-title":"Managing toxicities of high-dose interleukin-2","volume":"16","author":"Schwartz","year":"2002","journal-title":"Oncology (Williston Park, N.Y.)"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215100_bb0260","doi-asserted-by":"crossref","first-page":"14823","DOI":"10.1038\/s41598-018-33167-7","article-title":"Laboratory diagnostics of murine blood for detection of mouse cytomegalovirus (MCMV)-induced hepatitis","volume":"8","author":"Stahl","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:42:00Z","timestamp":1788277320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826003985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":52,"alternative-id":["S2772950826003985"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215100","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Condensate enabled delivery of Fas and IL-2 receptor agonists promotes T regulatory responses to alloantigens","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"215100"}}